Prof Kamm is a gastroenterologist interested in developing improved treatments for gastrointestinal and pelvic floor disorders, such as inflammatory bowel disease and functional disorders. He runs basic science, translational and clinical strands of research in parallel across the same areas of interest, developing new treatments that encompass physiological, pharmacological, surgical and psychological therapies.
MECHANISTIC ROLE OF CHOLESTEROL IN NON-ALCOHOLIC STEATOHEPATITIS
Funder
National Health and Medical Research Council
Funding Amount
$533,541.00
Summary
Fatty liver is present in 15-30% of Australians, related to obesity, diabetes and heart attack. Two-thirds of cases reverse easily. The remainder evolve to non-alcoholic steatohepatitis (NASH), liver damage that can lead to cirrhosis and liver failure. This research seeks to find out why some cases of fatty liver lead to NASH, and whether cholesterol that accumulates in the livers of mice with NASH is what causes that damage. If so, we will find new ways to treat NASH by diet or drugs.